⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15274590 | 0.93 | — | — | |
| SCHEMBL21805094 | 0.91 | PLG (0.39) | — | |
| SCHEMBL1742470 | 0.88 | CES2 (0.44) | — | |
| SCHEMBL16095403 | 0.84 | — | — | |
| SCHEMBL11075590 | 0.84 | ROCK2 (0.36) | — | |
| SCHEMBL14892803 | 0.84 | TP53 (0.40) | — | |
| SCHEMBL20501606 | 0.84 | TP53 (0.40) | — | |
| SCHEMBL14892804 | 0.84 | TP53 (0.40) | — | |
| SCHEMBL11086822 | 0.84 | ROCK2 (0.36) | — | |
| SCHEMBL2951007 | 0.82 | POLB (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4489091-A | ESTERASE AND ANTIBODY INHIBITORS | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1984-12-18 | — | — | US | disclosed |
| US-4411911-A | Method of treating hyperlipidemia and inflammation with sulfonate derivatives | TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) | 1983-10-25 | — | — | US | disclosed |